SCHEMBL3868558

SCHEMBL3868558

CC(=O)OC[C@H](N)C(=O)OC[C@H](N)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 3/20 0.51
NOS1 P29475 3/20 0.51
NOS2 P35228 3/20 0.51
SLC1A5 Q15758 1/20 0.41
SLC7A5 Q01650 2/20 0.40
GRIK1 P39086 4/20 0.39
IDO1 P14902 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
PTGS1 P23219 2/20 0.38
SLC7A11 Q9UPY5 1/20 0.38
SLC1A3 P43003 4/20 0.36
SLC1A2 P43004 4/20 0.36
SLC1A1 P43005 3/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
HSD17B10 Q99714 1/20 0.36
GRIK2 Q13002 3/20 0.35
GRM8 O00222 1/20 0.35
GRM6 O15303 1/20 0.35
GRIN2D O15399 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL770416 0.94 NOS3 (0.56) NOS3NOS1NOS2SLC1A5SLC7A5
SCHEMBL9980878 0.94 NOS3 (0.56) NOS3NOS1NOS2SLC1A5SLC7A5
SCHEMBL770417 0.94 NOS3 (0.56) NOS3NOS1NOS2SLC1A5SLC7A5
SCHEMBL598363 0.94 NOS3 (0.56) NOS3NOS1NOS2SLC1A5SLC7A5
Hydrochloric Acid SCHEMBL7592766 0.91 NOS1 (0.55) NOS3NOS1NOS2SLC1A5SLC7A5
Hydrochloric Acid SCHEMBL19209653 0.91 NOS1 (0.55) NOS3NOS1NOS2SLC1A5SLC7A5
Hydrogen Sulfide SCHEMBL22463012 0.91 NOS3 (0.55) NOS3NOS1NOS2SLC1A5SLC7A5
Hydrogen Sulfide SCHEMBL27825542 0.91 NOS3 (0.55) NOS3NOS1NOS2SLC1A5SLC7A5
Serine SCHEMBL3868560 0.86 NOS3 (0.50) NOS3NOS1NOS2SLC1A5SLC7A5
Serine SCHEMBL3868555 0.86 NOS3 (0.50) NOS3NOS1NOS2SLC1A5SLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1281759-B1 METHOD OF INHIBITING THE FORMATION OF BY-PRODUCT IN THE PRODUCTION OF GENETICALLY MODIFIED POLYPEPTIDE ASUBIO PHARMA CO LTD (JP) 2009-07-08 EP disclosed
US-7547529-B1 Methods for reducing the formation of by-products in the production of recombinant polypeptides ASUBIO PHARMA CO., LTD. (JP) 2009-06-16 US disclosed
EP-1281759-A1 METHOD OF INHIBITING THE FORMATION OF BY-PRODUCT IN THE PRODUCTION OF GENETICALLY MODIFIED POLYPEPTIDE SUNTORY LIMITED (JP) 2003-02-05 EP disclosed